Insider Transactions in Q2 2022 at Atara Biotherapeutics, Inc. (ATRA)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 27
2022
|
Pascal Touchon President and CEO |
SELL
Open market or private sale
|
Direct |
14,220
-2.92%
|
$99,540
$7.2 P/Share
|
|
Jun 23
2022
|
Beth C Seidenberg |
BUY
Grant, award, or other acquisition
|
Direct |
20,500
+25.89%
|
-
|
|
Jun 23
2022
|
Ronald C Renaud Jr |
BUY
Grant, award, or other acquisition
|
Direct |
20,500
+39.42%
|
-
|
|
Jun 23
2022
|
Eric Dobmeier |
BUY
Grant, award, or other acquisition
|
Direct |
20,500
+25.63%
|
-
|
|
Jun 23
2022
|
Roy D. Baynes |
BUY
Grant, award, or other acquisition
|
Direct |
20,500
+32.03%
|
-
|
|
Jun 23
2022
|
Maria Grazia Roncarolo |
BUY
Grant, award, or other acquisition
|
Direct |
20,500
+39.42%
|
-
|
|
Jun 23
2022
|
Ameet Mallik |
BUY
Grant, award, or other acquisition
|
Direct |
20,500
+50.0%
|
-
|
|
Jun 23
2022
|
Matthew K Fust |
BUY
Grant, award, or other acquisition
|
Direct |
20,500
+28.28%
|
-
|
|
Jun 23
2022
|
William K Heiden |
BUY
Grant, award, or other acquisition
|
Direct |
20,500
+28.28%
|
-
|
|
Jun 23
2022
|
Carol Giltner Gallagher |
BUY
Grant, award, or other acquisition
|
Direct |
20,500
+13.41%
|
-
|
|
Jun 08
2022
|
Utpal Koppikar Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,853
-2.8%
|
$29,265
$5.63 P/Share
|
|
May 17
2022
|
Pascal Touchon President and CEO |
SELL
Open market or private sale
|
Direct |
13,913
-2.78%
|
$69,565
$5.32 P/Share
|
|
May 17
2022
|
Jakob Dupont EVP, Head of R&D |
SELL
Open market or private sale
|
Direct |
3,873
-2.32%
|
$19,365
$5.32 P/Share
|
|
May 17
2022
|
Utpal Koppikar Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,582
-1.31%
|
$27,910
$5.32 P/Share
|
|
May 17
2022
|
Amar Murugan EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,223
-1.18%
|
$16,115
$5.32 P/Share
|